Contract development and manufacturing organization (CDMO) Recipharm and contract research organization (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones.
Recipharm Pathway to Clinic takes projects from early phase formulation development through to clinical trial implementation with patients, helping companies, ranging from small, virtual firms to big pharma, quickly generate data and build value in their compound.
From its development sites in Solna and Uppsala, Sweden, Recipharm performs formulation development, GMP clinical supply manufacture and bioanalysis on behalf of its clients. This will be closely integrated with CTC’s clinical trial capability and know-how of managing phase I trials at the Akademiska University Hospital in Uppsala.
“Our customers often face problems in terms of meeting timelines, adhering to changing regulations and managing trial complexity and it is our job to guide them through the process. Quite simply, Recipharm’s Pathway to Clinic service means we take responsibility for the full phase I programme, from formulation to clinical trial implementation with patients,” Torkel Gren, General Manager at Recipharm in Solna said.